Dmitry Balyasny’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Dmitry Balyasny’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-588,758	Closed	-$14.2M	–	3186
2023 Q1	$14.2M	Buy	+588,758	New	+$7.39M	0.04%	640

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Dmitry Balyasny's PRVB Position: Q2 2023 in Review

Dmitry Balyasny sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 588,758 shares — an estimated $14.2M sold.

Dmitry Balyasny first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $14.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Dmitry Balyasny reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Dmitry Balyasny sold 588,758 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $14.2M.
Dmitry Balyasny first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Dmitry Balyasny's Provention Bio, Inc. Common Stock position peaked at $14.2M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.